Browse related articlesHealthy bones campaign launched
United Arab Emirates: Thursday, March 20 - 2008 at 09:01
Novartis Consumer Health has launched a campaign to promote awareness of osteoporosis, a ‘silent crippler’ that is still prevalent among women in the Middle East. Some 70% of post menopausal women in the UAE have low bone mass, and its Building Strong Bones Campaign aims to educate women on the problem and provide advice on preventative measures. It is offering free bone examinations, alternating weekly between Boots pharmacy at Mall of the Emirates and Deira City Centre as well as at selected Ministry of Health Clinics.
- ADD ARTICLE TO
del.icio.us
Digg">
Also consider reading:
- » Oman to build $1bn healthcare city
- » Oman's pharmaceutical market looks bright
- » Pfizer to set up UAE research centre
- » Julphar to open new plants
- » Sex pills sold over the counter
- » e-TQM offers health masters course
- » Fewer UAE nationals seek care abroad
- » Maternity hospital for Sharjah
- » Mideast medicines up 18% yearly
- » Saudi okays center for blood disease
StaffThursday, March 20 - 2008 at 09:01 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Web Feeds